Bridgeway Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Bridgeway Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$373K	Sell	25,000 -15,500	-38%	-$345K	0.01%	883
2025 Q4	$1.01M	Sell	40,500 -29,500	-42%	-$525K	0.02%	703
2025 Q3	$685K	Buy	70,000 +20,000	+40%	+$120K	0.01%	753
2025 Q2	$213K	Buy	+50,000	New	+$223K	0.01%	949
2023 Q4	–	Sell	-86,487	Closed	-$1.07M	–	1404
2023 Q3	$1.07M	Sell	86,487 -29,200	-25%	-$298K	0.03%	694
2023 Q2	$1.04M	Hold	115,687	–	–	0.03%	719
2023 Q1	$401K	Sell	115,687 -22,000	-16%	-$89.7K	0.01%	933
2022 Q4	$337K	Buy	137,687 +8,100	+6%	+$23.6K	0.01%	967
2022 Q3	$358K	Buy	+129,587	New	+$550K	0.01%	984

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Bridgeway Capital Management's OLMA Position: Q1 2026 in Review

Bridgeway Capital Management reduced its Olema Pharmaceuticals (OLMA) stake by 38% in Q1 2026, selling an estimated $345K and leaving 25,000 shares worth $373K. The position accounts for 0.01% of the portfolio, ranked #883.

Bridgeway Capital Management first reported a position in OLMA in Q3 2022 and has held it in 9 quarters since. The position peaked at $1.07M in Q3 2023. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

Bridgeway Capital Management held 25,000 shares of Olema Pharmaceuticals worth $373K as of Q1 2026.
Bridgeway Capital Management sold 15,500 Olema Pharmaceuticals shares in Q1 2026, an estimated $345K.
Olema Pharmaceuticals made up 0.01% of Bridgeway Capital Management's portfolio in Q1 2026, its #883 holding.
Bridgeway Capital Management first reported a position in Olema Pharmaceuticals in Q3 2022 and has held it in 9 quarters since.
Bridgeway Capital Management's Olema Pharmaceuticals position peaked at $1.07M in Q3 2023.
195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.